A/Prof Mark Pinkham
CNE Management Committee
Mark Pinkham BM BCh MA (Hons) (Oxon) FRANZCR is a Radiation Oncologist and fulltime academic clinician working at Princess Alexandra Hospital (PAH), Gamma Knife Centre of Queensland and also ICON Cancer Care in Brisbane. He is Adjunct Professor at Queensland University of Technology (QUT) and Honorary Associate at the NHMRC Clinical Trials Centre (University of Sydney).
Following admission as a Fellow to the Royal Australian and New Zealand College of Radiologists (RANZCR) in 2014, he completed a post-graduate fellowship in neuro-oncology and stereotactic radiosurgery (SRS) at the world-renowned Christie Hospital in the UK and was appointed as a Staff Specialist at PAH in 2015. Since then, his clinical practice has involved almost exclusively caring for patients with primary and secondary brain tumours.
He is an experienced clinical researcher and current member of the Scientific Advisory Committee within Co-operative Group in Neuro-Oncology (COGNO) and Chair of the CNS Working Party within the Trans Tasmin Radiation Oncology Group (TROG). Since 2015, he has published over 40 peer-reviewed manuscripts and 2 book chapters. His research has focused on technical innovation for the treatment of brain tumours and improving survivorship aspects of clinical care.
Selected Publications
Dulfikar A, Koh ES, Lwin Z, Hovey E, Dhillon H, Arundell J, Pinkham E, Pinkham MB, Holland J, Trajano G, Naumann F. Physical functional capacity of patients with glioma prior to adjuvant radiation: preliminary descriptive study. Neurooncol Pract. 2021 Feb 22;8(3):290-298. doi: 10.1093/nop/npab015
Eitz KA, Lo SS, Soliman H, Sahgal A, Theriault A, Pinkham MB, Foote MC, Song AJ, Shi W, Redmond KJ, Gui C, Kumar AMS, Machtay M, Meyer B, Combs SE. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases. JAMA Oncol. 2020 Dec 1;6(12):1901-1909. doi: 10.1001/jamaoncol.2020.4630
Jenkins M, Lusk R, Foley H, Pinkham MB, Olson S, Hall B, McBean A, Jones C, Foote M. Leksell Gamma Knife® - The first 1000 patients from the radiation therapist's perspective. J Med Radiat Sci. 2021 Sep;68(3):320-325. doi: 10.1002/jmrs.440
Ownsworth T, Chan RJ, Jones S, Robertson J, Pinkham MB. Use of telehealth platforms for delivering supportive care to adults with primary brain tumors and their family caregivers: A systematic review. Psychooncology. 2021 Jan;30(1):16-26. doi: 10.1002/pon.5549
Pinkham MB, Whitfield GA, Brada M. New developments in intracranial stereotactic radiotherapy for metastases. Clin Oncol (R Coll Radiol). 2015 May;27(5):316-23. doi: 10.1016/j.clon.2015.01.007
Pinkham MB, Telford N, Whitfield GA, Colaco RJ, O'Neill F, McBain CA. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation. Clin Oncol (R Coll Radiol). 2015 Aug;27(8):445-53. doi: 10.1016/j.clon.2015.04.008
Pinkham MB, Sanghera P, Wall GK, Dawson BD, Whitfield GA. Neurocognitive Effects Following Cranial Irradiation for Brain Metastases. Clin Oncol (R Coll Radiol). 2015 Nov;27(11):630-9. doi: 10.1016/j.clon.2015.06.005
Pinkham MB, Bertrand KC, Olson S, Zarate D, Oram J, Pullar A, Foote MC. Hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas? J Clin Neurosci. 2014 Jan;21(1):86-90. doi: 10.1016/j.jocn.2013.04.005
Huo M, Foley H, Pinkham M, Shanker M, Bernard A, Jenkins M, Olson S, Hall B, Watkins T, Jones C, Foote M. Stereotactic radiotherapy for large vestibular schwannomas: Volume change following single fraction versus hypofractionated approaches. J Radiosurg SBRT. 2020;7(1):11-17. PMID: 32802574; PMCID: PMC7406344
Jacobson S, Jones C, Lusk R, Jenkins M, Chamunyonga C, Pinkham MB, Brown E. Clinical impact of magnetic resonance imaging distortions on gamma knife radiosurgery. J Med Radiat Sci. 2021 Sep;68(3):274-281. doi: 10.1002/jmrs.472